New research revealed contrasting roles for the SNAP23 protein in pancreatic secretion of digestive enzymes and hormones such as insulin. Inhibiting SNAP23 with a potential new diabetes drug enabled an alternative related protein of higher efficacy to compensate for its function and increase insulin secretion in mice. The novel therapy also shows promise as a treatment for pancreatitis.